INTRODUCTION
GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined.
OBJECTIVES
Our goal was to investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.
METHODS
We first identified a segregating GCH1 p.Ser80Asn variant in...
Yi-Wen Tay, A. Lee, J. Schee et al.· Movement Disorders· 0 citations
A convergent molecular signature linking PD and COVID-19 is identified, pronounced in comorbid individuals and characterized by interferon-driven innate immune activation, glial inflammatory responses, and dysregulation of lipid metabolic homeostasis, a model in which severe viral infection amplifies biological pathway...
M. M. Belyea, M. Shafiq, J. Laß et al.· medRxiv· 0 citations
BACKGROUND
Reliable biomarkers for Parkinson's disease (PD) pathology detection are essential for research. α-Synuclein (aSyn) seed amplification assay (SAA) is a validated biomarker for misfolded aSyn.
OBJECTIVE
The aim was to assess the association between aSyn SAA and LRRK2-related PD (LRRK2-PD) and its link to mi...
Theresa Lüth, C. Gabbert, T. Kleinz et al.· Movement Disorders· 0 citations
Adaptive sampling is a versatile genetic diagnostic tool in neurodegenerative disorders, while enabling cost-effective multiplexing, and further validation and improvements in bioinformatic analysis are needed.
A. Fienemann, J. C. Prietzsche, Joshua Laβ et al.· npj Parkinson's Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.